Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,018B 10.61B 9.33B 8.82B 8B 15.03B 15.12B 106B 40.8B 520B 39.83B 38.97B 1,670B P/E 2027 *
27.3x
P/E 2028 * 21.1x
Enterprise Value 987B 10.28B 9.04B 8.55B 7.75B 14.56B 14.65B 102B 39.53B 504B 38.59B 37.76B 1,618B EV / Sales 2027 *
2.8x
EV / Sales 2028 * 2.46x
Free-Float
69.7%
Yield 2027 *
0.62%
Yield 2028 * 0.69%
1 day+1.64%
1 week+1.71%
Current month+4.94%
1 month+3.80%
3 months-9.44%
6 months-4.64%
Current year-3.82%
1 week 1,194.9
Extreme 1194.9
1,229.8
1 month 1,131.05
Extreme 1131.05
1,229.8
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Global Head of Quality and PV

35,600 0.0043% -
12/18/25 Other

Chairman

85,738,125 10.2732%
12/18/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
+1.64%+1.71%-2.41%+12.66% 10.45B
+0.11%+1.71%+63.52%+117.61% 1,055B
+0.27%+0.92%+51.33%+73.35% 654B
+0.73%+0.68%+20.70%+74.90% 467B
-1.36%-2.58%+40.20%+42.33% 348B
+1.34%+4.53%+23.37%+29.55% 275B
-0.48%-0.54%+13.56%+13.50% 258B
+0.85%+6.35%+53.17%+54.39% 224B
+0.85%+1.10%+35.78%+101.82% 187B
-0.30%-2.98%-27.62%-61.28% 171B
Average +0.28%+0.74%+27.16%+45.88% 364.88B
Weighted average by Cap. -0.05%+1.01%+40.57%+69.68%

Financials

2027 *2028 *
Net sales 352B 3.67B 3.22B 3.05B 2.76B 5.19B 5.22B 36.5B 14.1B 180B 13.76B 13.46B 577B 393B 4.09B 3.6B 3.4B 3.09B 5.8B 5.83B 40.74B 15.74B 200B 15.36B 15.03B 644B
Net income 36.93B 385M 338M 320M 290M 545M 548M 3.83B 1.48B 18.85B 1.44B 1.41B 60.56B 48.82B 509M 447M 423M 384M 721M 725M 5.06B 1.96B 24.91B 1.91B 1.87B 80.06B
Net Debt -31.58B -329M -289M -274M -248M -466M -469M -3.28B -1.27B -16.12B -1.24B -1.21B -51.79B -51.62B -538M -473M -447M -406M -762M -766M -5.35B -2.07B -26.34B -2.02B -1.98B -84.64B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-09-28 ₹1,222.50 +1.64% 181,658
26-09-25 ₹1,202.80 +0.20% 28,644
26-09-24 ₹1,200.40 -0.80% 68,991
26-09-23 ₹1,210.10 -0.16% 43,537
26-09-22 ₹1,212.00 +0.83% 147,555
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
38
Last Close Price
1,222.50INR
Average target price
1,264.48INR
Spread / Average Target
+3.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock